O'CONNOR DANIEL J. (President and CEO) received a stock award from AMBRX BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 12/11/2023ACC: 0000950170-23-069446
DirectorOfficer· President and CEO
Since Oct 2023
+750K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
750K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+750K
Price / share
—
Trade value
—
% of position
122.3%
12/11/2023
613.33K→1.36M
Total
Net shares
+750K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/11/2023 | A · Award | +750K | — | — | 122.3% | 613.33K | 1.36M |
| Total | +750K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported